Sophie Dobiasch

Closest collaborators

The 25 strongest of 49 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Stephanie Elisabeth Combs · 9 shared papers, 2018–2025 · strength 1.44
   • Paper Identification of the unfolded protein response pathway as target for radiosensitization in pancreatic cancer. DOI 10.1016/j.radonc.2023.110059↗
   • Paper Comparison of 3 Positioning Techniques for Fractionated High-precision Radiotherapy in an Orthotopic Mouse Model of Pan… DOI 10.30802/aalas-cm-22-000060↗
   • Paper Development of a translational radiobiology platform using pancreatic cancer patient-derived organoids for personalized… DOI 10.1016/j.tranon.2025.102535↗
2. Roland Michael Schmid · 5 shared papers, 2020–2025 · strength 0.84
   • Paper Identification of the unfolded protein response pathway as target for radiosensitization in pancreatic cancer. DOI 10.1016/j.radonc.2023.110059↗
   • Paper Development of a translational radiobiology platform using pancreatic cancer patient-derived organoids for personalized… DOI 10.1016/j.tranon.2025.102535↗
   • Paper Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal aden… DOI 10.1038/s41551-024-01273-9↗
3. Günter Schneider · 4 shared papers, 2020–2025 · strength 0.63
   • Paper Identification of the unfolded protein response pathway as target for radiosensitization in pancreatic cancer. DOI 10.1016/j.radonc.2023.110059↗
   • Paper Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal aden… DOI 10.1038/s41551-024-01273-9↗
   • Paper Impact of DNA repair and reactive oxygen species levels on radioresistance in pancreatic cancer. DOI 10.1016/j.radonc.2021.03.038↗
4. Christian Schneeweis · 2 shared papers, 2024–2025 · strength 0.40
   • Paper Identification of the unfolded protein response pathway as target for radiosensitization in pancreatic cancer. DOI 10.1016/j.radonc.2023.110059↗
   • Paper Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal aden… DOI 10.1038/s41551-024-01273-9↗
5. Lily Nguyen · 3 shared papers, 2020–2021 · strength 0.38
   • Paper Modification of radiosensitivity by Curcumin in human pancreatic cancer cell lines. DOI 10.1038/s41598-020-60765-1↗
   • Paper Impact of DNA repair and reactive oxygen species levels on radioresistance in pancreatic cancer. DOI 10.1016/j.radonc.2021.03.038↗
   • Paper The Emerging Role of miRNAs for the Radiation Treatment of Pancreatic Cancer. DOI 10.3390/cancers12123703↗
6. Maximilian Reichert · 2 shared papers, 2025 · strength 0.36
   • Paper Development of a translational radiobiology platform using pancreatic cancer patient-derived organoids for personalized… DOI 10.1016/j.tranon.2025.102535↗
   • Paper Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal aden… DOI 10.1038/s41551-024-01273-9↗
7. Jan J. Wilkens · 2 shared papers, 2021–2022 · strength 0.36
   • Paper Comparison of 3 Positioning Techniques for Fractionated High-precision Radiotherapy in an Orthotopic Mouse Model of Pan… DOI 10.30802/aalas-cm-22-000060↗
   • Paper Histopathological Tumor and Normal Tissue Responses after 3D-Planned Arc Radiotherapy in an Orthotopic Xenograft Mouse … DOI 10.3390/cancers13225656↗
8. S. Kampfer · 2 shared papers, 2021–2022 · strength 0.36
   • Paper Comparison of 3 Positioning Techniques for Fractionated High-precision Radiotherapy in an Orthotopic Mouse Model of Pan… DOI 10.30802/aalas-cm-22-000060↗
   • Paper Histopathological Tumor and Normal Tissue Responses after 3D-Planned Arc Radiotherapy in an Orthotopic Xenograft Mouse … DOI 10.3390/cancers13225656↗
9. Wilko Weichert · 2 shared papers, 2021–2025 · strength 0.34
   • Paper Development of a translational radiobiology platform using pancreatic cancer patient-derived organoids for personalized… DOI 10.1016/j.tranon.2025.102535↗
   • Paper Histopathological Tumor and Normal Tissue Responses after 3D-Planned Arc Radiotherapy in an Orthotopic Xenograft Mouse … DOI 10.3390/cancers13225656↗
10. Jana Kern · 1 shared paper, 2024 · strength 0.24
    • Paper Identification of the unfolded protein response pathway as target for radiosensitization in pancreatic cancer. DOI 10.1016/j.radonc.2023.110059↗
11. Klaus Felix · 4 shared papers, 2015–2018 · strength 0.23
    • Paper Preoperative Serum Thymidine Kinase Activity as Novel Monitoring, Prognostic, and Predictive Biomarker in Pancreatic Ca… DOI 10.1097/mpa.0000000000000966↗
    • Paper Differential Diagnosis of Autoimmune Pancreatitis From Pancreatic Cancer by Analysis of Serum Gelatinase Levels. DOI 10.1097/mpa.0000000000000576↗
    • Paper Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targe… DOI 10.1186/s12951-016-0236-3↗
12. H. Carlo Maurer · 1 shared paper, 2025 · strength 0.21
    • Paper Development of a translational radiobiology platform using pancreatic cancer patient-derived organoids for personalized… DOI 10.1016/j.tranon.2025.102535↗
13. Felix Orben · 1 shared paper, 2025 · strength 0.21
    • Paper Development of a translational radiobiology platform using pancreatic cancer patient-derived organoids for personalized… DOI 10.1016/j.tranon.2025.102535↗
14. Christopher Keßler · 1 shared paper, 2025 · strength 0.21
    • Paper Development of a translational radiobiology platform using pancreatic cancer patient-derived organoids for personalized… DOI 10.1016/j.tranon.2025.102535↗
15. İhsan Ekin Demir · 1 shared paper, 2025 · strength 0.21
    • Paper Development of a translational radiobiology platform using pancreatic cancer patient-derived organoids for personalized… DOI 10.1016/j.tranon.2025.102535↗
16. Katja Peschke · 1 shared paper, 2025 · strength 0.15
    • Paper Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal aden… DOI 10.1038/s41551-024-01273-9↗
17. Stefanie Bärthel · 1 shared paper, 2025 · strength 0.15
    • Paper Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal aden… DOI 10.1038/s41551-024-01273-9↗
18. Jacco van Rheenen · 1 shared paper, 2025 · strength 0.15
    • Paper Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal aden… DOI 10.1038/s41551-024-01273-9↗
19. Georgios A. Kaissis · 1 shared paper, 2025 · strength 0.15
    • Paper Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal aden… DOI 10.1038/s41551-024-01273-9↗
20. Aristeidis Papargyriou · 1 shared paper, 2025 · strength 0.15
    • Paper Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal aden… DOI 10.1038/s41551-024-01273-9↗
21. Andreas R. Bausch · 1 shared paper, 2025 · strength 0.15
    • Paper Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal aden… DOI 10.1038/s41551-024-01273-9↗
22. Irina Heid · 1 shared paper, 2025 · strength 0.15
    • Paper Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal aden… DOI 10.1038/s41551-024-01273-9↗
23. Sebastian Lange · 1 shared paper, 2025 · strength 0.15
    • Paper Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal aden… DOI 10.1038/s41551-024-01273-9↗
24. Sebastian Mueller · 1 shared paper, 2025 · strength 0.15
    • Paper Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal aden… DOI 10.1038/s41551-024-01273-9↗
25. Roland Rad · 1 shared paper, 2025 · strength 0.15
    • Paper Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal aden… DOI 10.1038/s41551-024-01273-9↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.